PTPI — Petros Pharmaceuticals, Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1815903 ·
Last close
$0.00
Market Cap
$169.5K
52W High
$0.03
52W Low
$0.00
ADV30
100,267
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -988,501 | -955,625 | 3,545,719 | 3,488,595 | 2,844,825 |
| Mar 2026 | 0 | — | -1,027,179 | -987,036 | 4,394,450 | 4,352,450 | 2,623,135 |
| Dec 2025 | 0 | — | -391,486 | -336,506 | 5,163,598 | 5,136,722 | 2,292,744 |
| Sep 2025 | 0 | — | -990,737 | -922,723 | 6,133,468 | 6,070,266 | 2,765,381 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-4,033,060
Investing CF
$-5,449
Financing CF
$-545,544
CapEx
$-5,449
Dividends Paid
—
Buybacks
$-341,560
EPS Diluted TTM
$-10.72
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-112,281,812
Inventory
$1,302,484
Receivables
$443,555
ST Investments
—
EBIT TTM
$-4,210,180
Pretax Income TTM
$-4,287,537
Interest Exp TTM
$167,459
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -4,641,350 | 1,913,595 | 5,163,598 | 2,292,744 | 2,870,854 | -6,734,707 |
| Dec 2024 | 0 | -4,626,943 | -14,318,790 | 10,635,310 | 18,102,888 | -7,467,578 | -2,603,051 |
| Dec 2023 | 5,822,388 | -10,762,364 | -8,163,188 | 33,795,795 | 21,315,772 | 12,480,023 | -7,626,529 |
| Dec 2022 | 5,992,054 | -15,845,690 | -20,037,573 | 32,421,214 | 15,718,747 | 16,702,467 | -12,797,325 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.09
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RGBP | Regen BioPharma Inc | $167.5K | $0.00 | — |
| CNBX | CNBX Pharmaceuticals Inc. | $160.6K | $0.00 | — |
| PRPH | ProPhase Labs, Inc. | $155.9K | $0.01 | — |
| OCEA | Ocean Biomedical, Inc. | $185.9K | $0.00 | — |
| AVCRF | Avricore Health Inc. | $101.1K | $0.00 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.